Discontinued — last reported Q1 '25
Labcorp Holdings LabCorp Diagnostics — Goodwill increased by 0.6% to $5.13B in Q1 2025 compared to the prior quarter. Year-over-year, this metric grew by 3.7%, from $4.95B to $5.13B. Over 3 years (FY 2021 to FY 2024), LabCorp Diagnostics — Goodwill shows an upward trend with a 8.6% CAGR.
A high balance indicates significant historical acquisition activity; a sudden decrease may signal impairment or write-downs.
This represents the intangible asset value recorded when the company acquires other businesses at a premium over the fai...
Standard balance sheet item for companies that grow through frequent M&A activity.
lh_segment_labcorp_diagnostics_goodwill| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.82B | $4.02B | $4.05B | $4.14B | $4.19B | $4.43B | $4.53B | $4.51B | $4.57B | $4.75B | $4.81B | $4.95B | $4.94B | $5.15B | $5.10B | $5.13B |
| QoQ Change | — | +5.3% | +0.6% | +2.4% | +1.1% | +5.8% | +2.3% | -0.4% | +1.2% | +3.9% | +1.4% | +2.7% | -0.0% | +4.2% | -1.0% | +0.6% |
| YoY Change | — | — | — | — | +9.5% | +10.1% | +12.0% | +9.0% | +9.1% | +7.1% | +6.2% | +9.6% | +8.3% | +8.6% | +6.0% | +3.7% |